Join us on November 7, 2022, from 2-3:30pm ET for a presentation
"What's Up in Canada, Eh? Focus on Canadian Cancer Surveillance Research"
Registration is free at:
"The CanREValue Collaboration: Experience generating real-world evidence using real-world data from across Canada"
Presenter: Caroline Muñoz, MSc
The Canadian Real-world Evidence for Value in Cancer (CanREValue) Collaboration was established in 2017 to develop a framework for the generation and use of real-world evidence (RWE) of cancer drugs to inform drug funding decisions. This presentation will describe a demonstration project exploring the capacity to generate RWE in nine Canadian provinces, using data from cancer registries, hospital and emergency department records, and insurance claims, to provide direct, generalizable evidence on cancer drug effectiveness, safety, and cost-effectiveness.
"Lifetime probability of developing and dying from cancer in Canada, 1997-2020"
Presenter: JiaQi Leon Liu, MD, DrPH
The lifetime probability of developing and dying from cancer in Canada has been used as a measure of the general cancer experience among Canadians. This talk will present the most up-to-date estimates on lifetime probability of developing cancer up and lifetime probability of dying of cancer for Canadians.
"Central Nervous System Tumours in Canada from 2008-2017: Incidence, Prevalence and Survival"
Presenter: Emily Walker, PhD
This talk will present the most recent. comprehensive data on the incidence and prevalence of primary central nervous system (CNS) tumours in Canada, as well as the survival experience of Canadians diagnosed with a CNS tumour.
Angela Martin, CTR
Training Specialist/Project Coordinator
Phone: 217-698-0800 ext. 9
Education and Training Website: education.naaccr.org